Beam Therapeutics Inc. — Director's Dealing 2021

Apr 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-03-18

Reporting Person: Evans John M. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-18	Common Stock	L	33	$0.00	Acquired	1040365	Direct
2021-03-22	Common Stock	L	32	$0.00	Acquired	1040397	Direct
2021-03-31	Common Stock	L	32	$0.00	Acquired	1040429	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	223000	Indirect

Footnotes

F1: Distribution of BEAM common stock held by ARCH Venture Fund IX, L.P. to its partners for no consideration.